MOH Molina Healthcare, Inc.
XNYS
208.54
Delayed
Stock quote, options chain, IV rank, technicals, AI analysis, and institutional ownership. Iron condor setups Expected move IV rank history Fibonacci levels Insider trading
Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.
MOH
$208.54
—
Key stats
$208.54
After hours
$209.15
+0.00%
- 52-Week Range
- $121.06 – $244.89
- YTD
- +16.86%
- IV Rank (30D)
- 27.39
- Straddle Price
- $22.10
- P/C Vol Ratio
- 0.51
- Market Cap
- $11.3B
- Open
- $213.22
- Day Range
- $206.38 – $220.00
- Volume
- 1,265,851
- Prev Close
- $216.64
Fair Value
MODEL: NEUTRAL
A blended fair-value estimate combining up to six valuation methods. Each method is weighted by how well it fits the company — DCF down-weights for unprofitable names; DDM only fires for steady dividend payers; comparables down-weight when peer multiples disagree.
- DCF (quality-aware) — projects free cash flow with a horizon that scales to business quality. True compounders (quality 6/6) get 10 years explicit + 10 years fade before terminal; cyclical/struggling names (quality 0-1) get a 5-year terminal cliff. Quality is scored from ROE, gross margin, growth, FCF margin, debt load, and FCF consistency — the same factors that drive market premium for compounders.
- Market-Implied Growth (in Model Inputs) — reverse-DCF that answers "what growth rate is the market pricing in?". Lets you sanity-check the deviation: if implied growth is plausible for the business, the model's bearish flag may be wrong; if implausible, the market may be over-extrapolating.
- DDM (Gordon Growth Dividend Model) — values the stream of future dividends. Only used when trailing yield ≥ 2% and dividend payments are stable — below that the dividend is a token payout and Gordon (which values only the dividend stream) systematically underprices growth names, so those route to DCF + comparables + market anchor instead.
- P/E, EV/EBITDA, P/B, P/S — applies the peer-group median multiple to this company's per-share metric. Peers come from the same set as the "Related symbols" card. Earnings/sales metrics are forward-tilted by the company's recent revenue growth (capped at 25%) so they're comparable to peers' growth-embedded multiples — mimics how analysts use NTM rather than TTM. Per-multiple weights are biased by company quality (e.g. P/B down-weighted for asset-light tech).
- Market Anchor (SMA50) — the 50-day moving average, weighted by recent trading-range stability (tighter Bollinger bands → higher weight). Captures information fundamentals miss (forward consensus, sentiment, supply/demand) — but only when recent trading is steady enough that the market has converged on a view. During wild breakouts or breakdowns the anchor's weight collapses.
- Options Expected (B-L 30d) — the risk-neutral expected stock price at 30-day options expiration, derived from the full implied-volatility surface via Breeden-Litzenberger (second derivative of call price wrt strike → implied PDF, then E[S_T]). Forward-looking, captures all options-implied information (smile, skew, term structure) in one number. Weighted by chain liquidity. SP500-only at present (pre-computed daily). Backtest evidence: adds modest alpha across most bucket × holding combos.
- Blended value — weighted average. Confidence reflects how many methods fired and how tight peer dispersion is.
- Deviation pill — green when blended FV ≥ 10% above current price (undervalued); red when ≥ 10% below; grey otherwise.
| 10-yr Treasury (rf) | 5.12% |
| Beta vs SPY | 0.50 |
| Cost of Equity (CAPM) | 7.64% (VRP-adj) |
| WACC | 7.05% |
| Volatility Risk Premium | +11.6pp (IV − HV30) |
| Effective Tax Rate | 21.0% |
| Rev. Growth (YoY, DCF input) | -6.2% |
| DCF Horizon | 5 years explicit + fade |
| Free Cash Flow (TTM) | $0.3B |
| Return on Equity (TTM) | -0.2% |
| Book / Price | 37.1% — banking bias active (P/B is primary) |
| Gross Margin (TTM) | 12.3% |
| FCF Margin (TTM) | 0.6% |
| Debt / Equity | 0.95 |
| Quality Score | 0/6 — cyclical/struggling (5y DCF) |
| Market-Implied Growth | +14.5% (reverse-DCF on current price) |
| SMA 50 | $200.74 (Market Anchor value) |
| SMA 20 / Bollinger Mid | $200.52 |
| Bollinger Width / SMA20 | 10.9% (drives anchor stability) |
| Net Debt | $-1.0B |
| Market Cap | $11B |
Peers used for multiples: CI, ELV, HCSG, PGNY, THC, UNH, USPH
(filtered from 8 ETF-co-members; sector bias active)
60-Day Conviction
24%
20-Day Fair Value
≈ by Nov 23, 2026
$211.13
α +0.9%
rank 9%
conviction
59%
40-Day Fair Value
≈ by Dec 22, 2026
$214.13
α +2.4%
rank 9%
conviction
72%
60-Day Fair Value
≈ by Jan 20, 2027
$210.48
α +0.6%
rank 8%
conviction
24%
| Method | Implied Price | Weight | Detail |
|---|---|---|---|
| DCF | $98.63 | 0% | |
| DDM (Gordon) | n/a | 0% | |
| Peer P/E | $1.83 | 8% | median 18.3× · 7 peers |
| Peer EV/EBITDA | $71.27 | 4% | median 12.5× · 7 peers |
| Peer P/B | $230.54 | 12% | median 2.9× · 7 peers |
| Peer P/S | $708.47 | 4% | median 0.8× · 7 peers |
| Market Anchor (SMA50) | $200.74 | 49% | stability 95% (BB-width) |
| Options Expected (B-L 30d) | $216.82 | 24% | 19 strikes · skew +0.41 |
As of 2026-10-23 · updated
Related
About
- Industry (SIC)
- HOSPITAL & MEDICAL SERVICE PLANS (6324) · industry map
- Exchange
- XNYS
- Market Cap
- $11.3B
- Employees
- 19,000
- List Date
- 2003-07-02
- CIK
- 0001179929
- Headquarters
- Long Beach, CA
- Homepage
- https://www.molinahealthcare.com
Molina Healthcare Inc provides medical insurance plans through Medicaid, the individual exchanges, and Medicare. The company operates in four reportable segments consisting of: 1) Medicaid; 2) Medicare; 3) Marketplace; and 4) Other. It manages health benefit risks for more than 5 million people, with more than 85% of those members coming through contracts with state governments for their Medicaid programs. Medicaid contracts in four states-California, New York, Texas, and Washington-account for over half of its enrollees.
Summary
—
composite
—
No summary data available for this symbol yet.
Each spoke is this symbol's rank within its sector (0–100; the dotted ring marks the sector median at 50). Higher is more constructive for a long. One spoke — News sentiment — is an absolute reading, not a sector rank. Grayed spokes have no data. A fuller shape is a summary, not a recommendation.
Chart
Seasonality
| Month | '21 | '22 | '23 | '24 | '25 | '26 | Avg |
|---|---|---|---|---|---|---|---|
| Jan | -1.14% | -8.24% | -2.22% | -4.06% | 8.07% | 0.63% | -1.16% |
| Feb | 1.24% | 6.70% | -11.68% | 10.89% | -7.45% | -14.97% | -2.54% |
| Mar | 5.18% | 6.96% | -2.30% | 6.10% | 8.77% | -12.54% | 2.03% |
| Apr | 8.33% | -7.65% | 9.52% | -15.36% | -0.21% | 43.29% | 6.32% |
| May | -1.90% | -5.30% | -10.34% | -7.17% | -2.56% | -9.91% | -6.20% |
| Jun | 1.59% | -2.70% | 6.46% | -4.22% | 0.18% | 24.80% | 4.35% |
| Jul | 6.62% | 15.84% | 2.01% | 16.81% | -48.46% | -16.14% | -3.89% |
| Aug | -2.00% | 3.82% | 2.69% | 1.04% | 16.57% | 2.05% | 4.03% |
| Sep | 2.31% | -3.31% | 5.62% | -3.22% | 4.43% | -6.87% | -0.17% |
| Oct | 8.92% | 5.76% | 0.15% | -6.05% | -20.61% | 15.65%* | 0.64% |
| Nov | -4.29% | -5.39% | 8.53% | -8.83% | 0.84% | -- | -1.83% |
| Dec | 12.68% | -1.38% | -0.40% | -3.58% | 19.68% | -- | 5.40% |
| Total | 42.71% | 2.25% | 5.65% | -19.87% | -36.30% | 11.13% | 0.93% |
Technical Indicators
Quick-reference for reading the values below. Indicators combine to confirm a view — no single one is a trade signal on its own.
Trend Indicators
- SMA 20 / 50 / 200 — price above = uptrend, below = downtrend. SMA 50 crossing SMA 200 is the golden/death cross.
- EMA 12 / 26 — faster-reacting averages; 12 above 26 is short-term bullish.
- MACD — bullish when MACD > signal (green badge), bearish when below. Divergence from price often precedes reversals.
- ADX (14) — trend strength regardless of direction. <20 range, 20–25 weak trend, 25–50 trend, >50 strong trend.
- +DI / −DI — +DI > −DI favors bulls; the reverse favors bears. Read alongside ADX.
Momentum Oscillators
- RSI (14) — <30 oversold, >70 overbought. 40–60 is neutral; trending names can stay extreme.
- Stochastic %K / %D — <20 oversold, >80 overbought. %K crossing %D is an early momentum signal.
- Williams %R — inverted scale: <−80 oversold, >−20 overbought.
Oscillators work best in range-bound markets; in strong trends they give premature reversal signals.
Volume & Volatility
- Bollinger Bands — price at upper band = overbought, lower = oversold. Narrow bands (squeeze) often precede expansion.
- OBV — cumulative volume; rising OBV confirms uptrend, falling OBV confirms downtrend. Divergence from price is a warning.
- Vol SMA 20 / Vol ROC — today's volume vs. 20-day average. Positive ROC with price move = conviction.
- ATR / True Range — average daily $ move; sizing and stop-loss reference.
- HV 20 / 30 / 60 — realized (historical) volatility. Compare to IV on the options cards: IV > HV = rich premium.
Confluence matters: trend + momentum + volume agreeing carries far more weight than any single indicator. For how these feed the spread scanner score, see the algorithm docs →
Trend Indicators
SMA 20: $201.44
SMA 50: $200.81
SMA 200: $184.46
Current: $209.15
EMA 12: $208.86
EMA 26: $204.32
MACD: 4.5439 | Signal: 1.5704
BULLISH
ADX (14): 20.97
WEAK TREND
+DI: 19.56
−DI: 12.56
Momentum Oscillators
RSI (14): 54.75
NEUTRAL
Stoch %K: 70.40
Stoch %D: 81.06
Williams %R: -48.68
Volume & Volatility
BB Upper: $223.19
BB Lower: $179.68
NEUTRAL
OBV: -30,973,314
Vol SMA 20: 861,238
Vol ROC: 148.59%
ATR: $9.30
True Range: $13.62
HV 20: 38.6%
HV 30: 39.8%
HV 60: 36.3%
Data Summary
Data Points: 500
Last Updated:
Date Range: 2024-10-25T00:00:00 – 2026-10-23T00:00:00
AI Analysis
LLM Stock Analysis Report
Executive Summary
Overall Assessment: NEUTRAL with a confidence level of 6/10.
Key Drivers: The stock's recent price action has been influenced by the mixed news headlines, which have led to a neutral sentiment.
Primary Risks: The stock's beta is negative, indicating that it tends to move opposite to the market. This could amplify potential losses if the market turns bearish.
Investment Thesis: Molina Healthcare, Inc. (MOH) has been trading in a narrow range, and recent news headlines have not had a significant impact on its price movement. The stock's beta and volatility indicators suggest caution is warranted.
Recent News Sentiment Impact: The negative news headlines have contributed to the neutral sentiment, but their impact has been mitigated by the lack of any significant market-moving events.
Technical Analysis
Trend Direction:
- Short-term (1-4 weeks): Neutral
- Medium-term (1-3 months): Downtrend
- Long-term (3-12 months): Uptrend
Support/Resistance Levels: The stock is trading near its 50-day simple moving average (SMA) at $208.30.
Momentum Signals:
- RSI interpretation: Neutral, with a reading of 41.69.
- MACD signal: Bearish, with a histogram value of -4.18.
- Bollinger Bands position: Squeeze, indicating that the stock is trading within a tight range.
Volume Analysis: The volume indicators suggest institutional interest has been decreasing, and the stock's price movement has not been supported by significant buying or selling pressure.
News & Sentiment Analysis
Recent Headlines Summary: The news headlines have been mixed, with some negative articles about regulatory issues and others discussing general market commentary. However, none of these headlines have had a significant impact on the stock's price movement.
Sentiment Assessment: Neutral sentiment prevails, as the negative news headlines have not been enough to move the stock significantly.
Catalyst Identification: There are no immediate catalysts that could significantly impact the stock's price movement. However, the upcoming earnings report might provide some insights into the company's performance and future prospects.
Market Narrative: The market narrative suggests that the stock is trading in a narrow range, influenced by mixed news headlines and institutional interest.
Risk & Volatility Assessment
Beta Interpretation: The negative beta indicates that the stock tends to move opposite to the market, which could amplify potential losses if the market turns bearish.
Volatility Regime: The current volatility regime is moderate, with a historical volatility reading of 43.3%.
Options Market Signals:
- IV rank: Low
- Put/call ratios: Neutral
- Unusual activity: None
Downside Protection: The support level at $208.30 could provide some downside protection if the stock experiences a correction.
Market Context & Positioning
Sector Performance: The healthcare sector has been trading in line with the broader market, suggesting that MOH's performance is not exceptional relative to its peers.
Institutional Activity: Institutional interest has been decreasing, as evidenced by the volume indicators.
Correlation Analysis: The stock's correlation with the market is low (R-squared interpretation), indicating that it tends to move independently of the broader market.
Relative Valuation: The stock's relative valuation suggests that it is trading near its mean, which could indicate a neutral sentiment.
Key Levels & Action Items
Critical Price Levels:
- Support at $208.30
- Resistance at $239.96
Breakout/Breakdown Levels: None notable in the short term.
Time-Sensitive Catalysts: The upcoming earnings report might provide some insights into the company's performance and future prospects.
Risk Management: A stop-loss level could be set below the support level at $208.30 to limit potential losses if the stock experiences a correction.
By analyzing the data, it appears that Molina Healthcare, Inc. (MOH) is trading in a narrow range, influenced by mixed news headlines and institutional interest. The negative beta suggests caution is warranted, and the recent volume indicators suggest decreasing institutional interest. The upcoming earnings report might provide some insights into the company's performance and future prospects.
Generated
News
All MOH news →
Medicaid margins hit trough as Florida contract ramps and earnings harvest begins.
The healthcare-services provider’s third-quarter profit fell to $38 million from $79 million a year earlier, impacted by lower membership in Medicaid and Marketplace.
Earnings History
20 of 24 under expected move
Avg Expected Move
10.27%
Avg Actual Move
7.18%
| Earnings Date | Timing | Expected Move | Actual Move | Ratio | Outcome |
|---|---|---|---|---|---|
| 2021-02-10 | After-Close | 7.03% | 4.88% | 0.69x | Within |
| 2021-04-28 | After-Close | 7.42% | 2.06% | 0.28x | Within |
| 2021-07-28 | After-Close | 9.57% | 1.53% | 0.16x | Within |
| 2021-10-27 | After-Close | 7.61% | 0.51% | 0.07x | Within |
| 2022-02-09 | After-Close | 6.91% | 0.41% | 0.06x | Within |
| 2022-04-27 | After-Close | 8.99% | 2.61% | 0.29x | Within |
| 2022-07-27 | After-Close | 8.04% | 3.68% | 0.46x | Within |
| 2022-10-26 | After-Close | 6.78% | 4.72% | 0.70x | Within |
| 2023-02-08 | After-Close | 5.65% | 1.90% | 0.34x | Within |
| 2023-04-26 | After-Close | 7.80% | 7.75% | 0.99x | Within |
| 2023-07-26 | After-Close | 6.49% | 1.23% | 0.19x | Within |
| 2023-10-25 | After-Close | 7.50% | 1.50% | 0.20x | Within |
| 2024-02-07 | After-Close | 5.40% | 5.35% | 0.99x | Within |
| 2024-04-24 | After-Close | 6.44% | 4.11% | 0.64x | Within |
| 2024-07-24 | After-Close | 16.76% | 12.28% | 0.73x | Within |
| 2024-10-23 | After-Close | 15.48% | 17.67% | 1.14x | Exceeded |
| 2025-02-05 | After-Close | 11.80% | 10.09% | 0.86x | Within |
| 2025-04-23 | After-Close | 11.81% | 5.48% | 0.46x | Within |
| 2025-07-23 | After-Close | 14.48% | 16.84% | 1.16x | Exceeded |
| 2025-10-22 | After-Close | 14.79% | 17.49% | 1.18x | Exceeded |
| 2026-02-05 | After-Close | 14.36% | 25.51% | 1.78x | Exceeded |
| 2026-04-22 | After-Close | 15.10% | 14.18% | 0.94x | Within |
| 2026-07-22 | After-Close | 15.58% | 9.67% | 0.62x | Within |
| 2026-10-21 | After-Close | 14.61% | 0.81% | 0.06x | Within |
Earnings calendar: this week’s reports with expected vs actual moves →
MOH Options Activity & IV Rank
MOH IV rank history, 52-week IV rank and IV percentile →
Volatility Metrics
Current IV: 46.4%
7-DTE IV: —
Expected Move: $22.10
7-DTE Move: $22.10
Days to Exp: 28 (2026-11-20)
Options Flow
Call Volume: 265
Put Volume: 136
P/C Volume: 0.513
BULLISH
Call OI: 4,272
Put OI: 2,441
P/C OI: 0.571
Total OI: 6,713
ATM Options Pricing
ATM Call: $11.35
ATM Put: $10.75
Call %: 5.4%
Put %: 5.2%
Chain Summary
Chain Volume: 3,080
Chain OI: 27,178
Last Updated: 10/23/2026
Spread Scanner GPU
Each spread is ranked by a composite score built in three stages. Full documentation →
Stage 1 — Base Score (GPU scanner)
score = P(profit) × (credit / spread_width)
P(profit) from short leg delta (1 − |delta|), penalised above 85%. Credit uses mid-price to handle illiquid chains fairly.
Stage 2 — Skew Adjustment (±25% cap)
RR and BF (30-delta) from the persisted per-symbol skew snapshot — wing strikes picked by real greeks.delta, not a moneyness proxy. Put skew boosts bull puts, penalises bear calls. High butterfly boosts iron condors. Calendars are skew-neutral.
Stage 3 — Technical Overlay (±50% cap, 5 groups)
Group 1 · Directional Bias (±0.25)
- RSI <40 bullish / >60 bearish
- MACD crossover + histogram trend
- Price vs SMA 50 & SMA 200
Group 2 · Momentum (±0.10)
- Stochastic %K <20 / >80
- Williams %R <−80 / >−20
Group 3 · Volatility (up to −0.25 / +0.15)
- Blended ATR + straddle expected-move penalty
- Bollinger Band signal (+ counter-trend penalty)
- BB width — vol contraction boost for ICs
Group 4 · IV Regime (±0.15)
- IV rank ≥ 75 → strong boost for credit spreads
- IV rank < 25 → penalty (selling cheap vol)
Group 5 · Liquidity (penalty up to −0.10)
- Min open interest across all legs
- OI < 100 → −0.10 · OI < 500 → −0.05
score = base_score × skew_multiplier × tech_multiplier
Both multipliers are shown per spread. Beta is informational only — ATR already captures realized vol. Full algorithm documentation →
Enter a ticker to scan for optimal spread opportunities.
Evaluates all bull put, bear call, iron condor, and calendar spread combinations using GPU-accelerated analysis.
Dealer Positioning
TYPICAL γ
Estimated net dealer gamma is at the 43rd percentile of this name's own daily history, within its typical range. This describes current positioning; it is not a forecast or a trading signal.
Gamma percentile
43%
vs own history
GEX tilt
+0.00
OI-weighted, today
Vanna tilt
+0.59
δ-sensitivity to IV
Charm tilt
-0.67
δ-decay vs time
Vanna tilt +0.59: the estimated dealer exposure leans positive, so the modeled hedge would shift noticeably if implied volatility changed.
Charm tilt -0.67: the estimated dealer exposure leans negative, so the modeled hedge would shift noticeably as time passes and options approach expiry.
? What is this?
· 45 ATM contracts, 8k total OI
Net dealer gamma is an estimate of the aggregate gamma held by options market makers across this name's option chain, weighted by open interest. Dealer positions aren't public, so it uses a standard simplifying assumption: dealers are treated as long the calls and short the puts that are open. Actual dealer books can differ.
Gamma percentile ranks today's estimate against this name's own daily history, from 0% (the lowest reading on record) to 100% (the highest). Raw gamma scales with how much open interest a chain carries, so it isn't comparable across names; the percentile is. The badge marks the bottom 20% as low and the top 20% as high.
Tilts run from −1 to +1 and show how lopsided the estimated dealer exposure is. GEX tilt compares call gamma with put gamma. Vanna tilt describes how the hedge would shift if implied volatility changed, and charm tilt how it would shift with the passage of time.
This card describes estimated positioning and where it sits historically. It is not a forecast of price direction or volatility and not a trading signal. Market-wide view: Dealer positioning screener.
Skew (Wing IV − ATM IV)
DTE:
Wing Δ:
Wing vs ATM
IV(put wing) − IV(ATM), in vol pointsHow much the OTM put trades above (or below) the at-the-money strike. Measures the height of the put-side tail relative to ATM — i.e. how expensive crash insurance is on this name.
- Positive (typical) — wing IV > ATM IV. Standard equity put skew: portfolios bid up crash protection, so OTM puts trade richer than ATM.
- Near zero or negative (unusual) — wing IV ≤ ATM IV. Flat or inverted put side. Common when there's no fear demand, in tightly mean-reverting names, or right after an earnings catalyst clears.
- Percentile vs own 3-yr history: high = wings rich (good time to sell wing premium); low = wings cheap (good time to buy protection).
- Not directional — high or low wings don't predict up or down moves. It's a price tag on tail insurance, not a forecast.
Risk Reversal
IV(call wing) − IV(put wing), equal delta on each sideWhich side of the smile is the market paying up for? Measures the tilt of the surface — call skew vs put skew at matched deltas.
- Negative (typical) — puts richer than calls. Standard equity behavior: hedging demand makes puts carry a premium. Most large-caps sit in the −1 to −5 vol-point range.
- Strongly negative (< −5 pts) — heavy downside hedging, elevated fear, or an upcoming catalyst (earnings, FDA, macro event). Worth flagging.
- Positive — calls richer than puts. Unusual for equities; signals bullish momentum, short-squeeze positioning, or takeover/M&A speculation.
- Near zero — symmetric surface. Market sees roughly equal up/down risk. Rare for large-caps; more common in commodities and FX.
Reading them together
Wing-vs-ATM tells you how expensive the tails are. Risk Reversal tells you which side is favored. Combined:
- High wing percentile + deeply negative RR → strong put bid; stress or major event priced in. Owning protection costs a premium; selling put premium is dangerous.
- Low wing percentile + near-zero RR → complacency; insurance cheap and balanced. Good environment to add cheap downside hedges.
- Positive RR + elevated wings → call-side fear-of-missing-out; common in squeeze setups. Upside calls expensive, downside puts not bid.
14 DTE / 10d
—
—
pts
EXTREME
No data
30 DTE / 10d
24%
+3.9
pts
EXTREME
ATM 47.6% / Wing 51.4%
Extreme reading.
Historically these have been contrarian — on the small set of observed earnings-day cases, large negative wing-vs-ATM gaps (calls pricing much richer than puts at the same delta) preceded sharp drops in the underlying within 1-12 days. Not financial advice and the dataset is small.
Percentile is the rank of today's reading within ~3 years of this symbol's own history. High percentile = wings are rich relative to history; not a directional signal. Skew is read off the chain in real time, not from CBOE SKEW.
Volatility Surface
Enter a ticker to render the implied volatility surface.
Volatility Smile
Enter a ticker to render the implied volatility smile.
IV Rank (7 DTE)
IV Rank (30 DTE)27.4MediumOct 23
Straddle Price (30 DTE)$22.10Oct 23
Beta Analysis
Risk Metrics
Beta: -0.0718
Alpha: 40.58%
Correlation: -0.0181
R-Squared: 0.0%
Stock Volatility: 50.6%
Market Volatility: 12.7%
Analysis Details
Benchmark: SPY
Data Points: 251
Period: 252 trading days
Data Points: 251
Period: 252 trading days
Interpretation:
Negative beta - stock moves opposite to market
Negative beta - stock moves opposite to market
Beta & Alpha Over Time
Notable investors who own MOH
7 of 37 tracked investors
| Investor | Value | Share of their portfolio | Rank | Q/Q shares | Source |
|---|---|---|---|---|---|
| Baupost Group Hedge fund Seth Klarman | $144.9M | #13 of 23 | 0.0% | 13F | |
| Renaissance Technologies Hedge fund Jim Simons | $72.1M | #218 of 3138 | +1316.0% | 13F | |
| Scion Asset Management Hedge fund Michael Burry | $23.9M | #1 of 4 | new | 13F | |
| Millennium Management Hedge fund Izzy Englander | $19.0M | #1165 of 3716 | +112.7% | 13F | |
| Citadel Hedge fund Ken Griffin | $9.8M | #1606 of 6285 | -80.8% | 13F | |
| Bridgewater Associates Hedge fund Ray Dalio | $1.9M | #723 of 997 | +298.9% | 13F | |
| Rockefeller Capital Management Family office Rockefeller family | $215K | #2566 of 4729 | -33.8% | 13F |
Hedge funds, activists, holding companies and family offices we track, from their latest 13F (quarter-end value) and Form 4 filings in the last 3 years. Family offices · all institutions
MOH Institutional Ownership (13F)
Latest filings — 2026-09-30
? 13F Guide
Diluted shares outstanding: 51,925,000 (as of 2026-06-30)
Institutional managers with $100M+ AUM file Form 13F-HR quarterly, due 45 days after quarter end. Holdings are reported gross at quarter-end market value — they are a snapshot, not a real-time position.
- Shares — long equity positions in this name, aggregated across share classes.
- Calls / Puts — notional value of long call / put exposure where this ticker is the underlying.
- % of Float — holder's reported shares divided by the latest diluted shares outstanding. Sums above 100% indicate large custodian / prime broker positions where the same shares are reported by multiple filers.
- Custodian badge — filers with more than 5,000 holdings are typically broker-dealers / custodians reporting customer-held shares, not active managers.
Each filer is counted once at its latest 13F-HR filing. New filings are ingested on a weekly cadence.
20 filers$209.99M notional
| # | Filer | Notional Value | % of Total | Period |
|---|---|---|---|---|
| 1 | Susquehanna International Group, LLP Custodian | $46.36M | 22.08% | 2026-06-30 |
| 2 | Jane Street Group, LLC Custodian | $34.37M | 16.37% | 2026-06-30 |
| 3 | IMC-Chicago, LLC Custodian | $30.60M | 14.57% | 2026-06-30 |
| 4 | Citadel Advisors LLC Custodian | $23.94M | 11.40% | 2026-06-30 |
| 5 | Point72 Asset Management, L.P. | $17.59M | 8.38% | 2026-06-30 |
| 6 | Alphadyne Asset Management LP | $9.88M | 4.70% | 2026-06-30 |
| 7 | Millennium Management LLC Custodian | $9.86M | 4.69% | 2026-06-30 |
| 8 | Wolverine Trading, LLC Custodian | $8.07M | 3.84% | 2025-09-30 |
| 9 | Cubist Systematic Strategies, LLC | $6.79M | 3.23% | 2025-09-30 |
| 10 | Walleye Trading LLC | $5.51M | 2.62% | 2026-06-30 |
| 11 | D. E. Shaw & Co., Inc. Custodian | $4.83M | 2.30% | 2026-06-30 |
| 12 | Caption Management, LLC | $3.43M | 1.63% | 2026-06-30 |
| 13 | GROUP ONE TRADING LLC Custodian | $2.40M | 1.14% | 2026-06-30 |
| 14 | Simplex Trading, LLC Custodian | $2.26M | 1.08% | 2026-06-30 |
| 15 | Two Sigma Investments, LP Custodian | $1.46M | 0.70% | 2026-06-30 |
| 16 | Schonfeld Strategic Advisors LLC | $1.14M | 0.54% | 2026-06-30 |
| 17 | Squarepoint Ops LLC | $686.10K | 0.33% | 2026-06-30 |
| 18 | TUDOR INVESTMENT CORP ET AL | $411.66K | 0.20% | 2026-06-30 |
| 19 | Walleye Capital LLC | $365.92K | 0.17% | 2026-06-30 |
| 20 | Brooklands Fund Management Ltd | $31.20K | 0.01% | 2026-06-30 |
24 filers$311.01M notional
| # | Filer | Notional Value | % of Total | Period |
|---|---|---|---|---|
| 1 | Susquehanna International Group, LLP Custodian | $82.79M | 26.62% | 2026-06-30 |
| 2 | Jane Street Group, LLC Custodian | $43.22M | 13.90% | 2026-06-30 |
| 3 | JPMorgan Chase & Co Custodian | $39.02M | 12.55% | 2026-06-30 |
| 4 | Citadel Advisors LLC Custodian | $28.79M | 9.26% | 2026-06-30 |
| 5 | IMC-Chicago, LLC Custodian | $25.82M | 8.30% | 2026-06-30 |
| 6 | Alphadyne Asset Management LP | $14.13M | 4.54% | 2026-06-30 |
| 7 | Point72 Asset Management, L.P. | $12.76M | 4.10% | 2026-06-30 |
| 8 | Wolverine Trading, LLC Custodian | $9.17M | 2.95% | 2025-09-30 |
| 9 | TUDOR INVESTMENT CORP ET AL | $6.66M | 2.14% | 2026-06-30 |
| 10 | GROUP ONE TRADING LLC Custodian | $6.31M | 2.03% | 2026-06-30 |
| 11 | Bank of Montreal Custodian | $5.72M | 1.84% | 2026-06-30 |
| 12 | WOLVERINE ASSET MANAGEMENT LLC | $5.72M | 1.84% | 2026-06-30 |
| 13 | Cubist Systematic Strategies, LLC | $5.28M | 1.70% | 2025-09-30 |
| 14 | Caption Management, LLC | $5.15M | 1.65% | 2026-06-30 |
| 15 | Millennium Management LLC Custodian | $4.71M | 1.51% | 2026-06-30 |
| 16 | D. E. Shaw & Co., Inc. Custodian | $3.70M | 1.19% | 2026-06-30 |
| 17 | Walleye Trading LLC | $3.64M | 1.17% | 2026-06-30 |
| 18 | Simplex Trading, LLC Custodian | $2.47M | 0.79% | 2026-06-30 |
| 19 | Two Sigma Investments, LP Custodian | $2.10M | 0.68% | 2026-06-30 |
| 20 | SIG BROKERAGE, LP | $1.83M | 0.59% | 2026-06-30 |
| 21 | Schonfeld Strategic Advisors LLC | $1.14M | 0.37% | 2026-06-30 |
| 22 | Walleye Capital LLC | $434.53K | 0.14% | 2026-06-30 |
| 23 | BNP Paribas Financial Markets Custodian | $228.70K | 0.07% | 2026-06-30 |
| 24 | Squarepoint Ops LLC | $205.83K | 0.07% | 2026-06-30 |
MOH Insider Trading (Form 4)
Latest: 2026-10-02Form 4 filings — insider beneficial-ownership changes by officers, directors, and 10%+ holders. Filed within 2 business days of transaction.
| Filed | Reporter | Role | Action | Shares | Avg Price | Net $ | Link |
|---|---|---|---|---|---|---|---|
| 2026-10-02 | Francis S Soistman Jr | Director | Award (A) | +304 | $180.85 | $55.0K | EDGAR |
| 2026-10-02 | Stephen H Lockhart | Director | Award (A) | +304 | $180.85 | $55.0K | EDGAR |
| 2026-10-02 | Steven J Orlando | Director | Award (A) | +304 | $180.85 | $55.0K | EDGAR |
| 2026-10-02 | Dale B Wolf | Director | Award (A) | +304 | $180.85 | $55.0K | EDGAR |
| 2026-10-02 | Leo P Grohowski | Director | Award (A) | +304 | $180.85 | $55.0K | EDGAR |
| 2026-10-02 | Richard C Zoretic | Director | Award (A) | +304 | $180.85 | $55.0K | EDGAR |
| 2026-10-02 | Barbara L Brasier | Director | Award (A) | +304 | $180.85 | $55.0K | EDGAR |
| 2026-10-02 | Richard M Schapiro | Director | Award (A) | +304 | $180.85 | $55.0K | EDGAR |
| 2026-10-02 | Ronna Romney | Director | Award (A) | +304 | $180.85 | $55.0K | EDGAR |
| 2026-07-02 | Leo P Grohowski | Director | Award (A) | +237 | $232.55 | $55.1K | EDGAR |
| 2026-07-02 | Jeff D. Barlow | Chief Legal Officer | Award (A) | +138 | $147.51 | $20.4K | EDGAR |
| 2026-07-02 | James Woys | Chief Operating Officer | Award (A) | +144 | $147.51 | $21.2K | EDGAR |
| 2026-07-02 | Ronna Romney | Director | Award (A) | +237 | $232.55 | $55.1K | EDGAR |
| 2026-07-02 | Steven J Orlando | Director | Award (A) | +237 | $232.55 | $55.1K | EDGAR |
| 2026-07-02 | Barbara L Brasier | Director | Award (A) | +237 | $232.55 | $55.1K | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (described in filing footnote — typically 401(k), trust, inheritance) · W = will/inheritance. Only P / S codes carry directional signal.
MOH Insider Holdings
16 insiders · @ $209.15
Officers, directors, and 10%+ owners who have filed a Form 4 in the past two years, ranked by current disclosed exposure (shares × today's price). Shares are direct + indirect (via trusts / LLCs / spouse). Excludes unvested RSU and option grants — those aren't beneficially owned until vest.
| # | Insider | Role | Shares | Disclosed Exposure | Lifetime OM Net | Filings | Last Filed |
|---|---|---|---|---|---|---|---|
| 1 | Joseph M Zubretsky | President & CEO | 356,730 | $74.61M | -$155.16M | 18 | 2026-03-02 |
| 2 | James Woys | Chief Operating Officer | 90,178 | $18.86M | -$6.38M | 23 | 2026-07-02 |
| 3 | Mark Lowell Keim | Chief Financial Officer | 83,251 | $17.41M | -$9.76M | 15 | 2026-03-02 |
| 4 | Jeff D. Barlow | Chief Legal Officer | 67,313 | $14.08M | -$20.08M | 62 | 2026-07-02 |
| 5 | Steven J Orlando | Director | 45,750 | $9.57M | -$6.91M | 107 | 2026-10-02 |
| 6 | Ronna Romney | Director | 44,382 | $9.28M | -$5.61M | 146 | 2026-10-02 |
| 7 | Dale B Wolf | Director | 31,646 | $6.62M | -$6.44M | 69 | 2026-10-02 |
| 8 | Debra Bacon | EVP, Medicaid | 21,636 | $4.53M | -$198.1K | 9 | 2026-07-02 |
| 9 | Daniel Cooperman | Director | 14,929 | $3.12M | -$7.40M | 59 | 2025-04-02 |
| 10 | Maurice Hebert | Chief Accounting Officer | 12,815 | $2.68M | -$478.2K | 15 | 2026-05-15 |
Lifetime OM Net = signed sum of open-market buys (P) and sells (S) over their career; excludes grants, tax withholdings, and dispositions to issuer. A large negative number is normal for long-tenured executives — they've sold compensation grants over many years.
MOH Board & Officers
As of SEC filings through Oct 2, 2026Directors 10
- Steven J Orlando · on file since 2006
- Ronna Romney · on file since May 2006
- Dale B Wolf · since Mar 11, 2013
- Richard M Schapiro · since Jul 29, 2015
- Joseph M Zubretsky · since Nov 6, 2017
- Richard C Zoretic · since Aug 1, 2018
- Barbara L Brasier · since May 8, 2019
- Stephen H Lockhart · since May 6, 2021
- Leo P Grohowski · since Apr 30, 2025
- Francis S Soistman Jr · since May 6, 2026
Officers 6
- Joseph M Zubretsky · President & CEO · since Nov 6, 2017
- Mark Lowell Keim · Chief Financial Officer · listed since Mar 2021
- James Woys · Chief Operating Officer · listed since Jul 2023
- Jeff D. Barlow · Chief Legal Officer · listed since Feb 2014
- Maurice Hebert · Chief Accounting Officer · since Feb 19, 2019
- Debra Bacon · EVP, Medicaid · since Jan 24, 2024
Changes in the last 10 years (30)
| May 6, 2026 | Francis S Soistman Jr became a director |
| Apr 30, 2025 | Leo P Grohowski became a director |
| Jan 24, 2024 | Debra Bacon became EVP, Medicaid |
| Jul 3, 2023 | James Woys listed as Chief Operating Officer (previously EVP, Health Plan Services) in SEC filings |
| May 24, 2021 | Thomas L Tran reported in an SEC filing no longer being Chief Financial Officer |
| May 6, 2021 | Stephen H Lockhart became a director |
| Mar 3, 2021 | Mark Lowell Keim listed as Chief Financial Officer (previously Executive Vice President) in SEC filings |
| Mar 3, 2021 | Marc Russo listed as EVP, Health Plans (previously Executive Vice President) in SEC filings |
| Mar 3, 2021 | James Woys listed as EVP, Health Plan Services (previously Executive Vice President) in SEC filings |
| Mar 23, 2020 | Marc Russo became Executive Vice President |
| May 8, 2019 | Barbara L Brasier became a director |
| Feb 19, 2019 | Maurice Hebert became Chief Accounting Officer |
| Aug 1, 2018 | Richard C Zoretic became a director |
| Jun 6, 2018 | Joseph W Cpa White reported in an SEC filing no longer being Chief Financial Officer |
| May 24, 2018 | Thomas L Tran became Chief Financial Officer |
| May 14, 2018 | James Woys became Executive Vice President |
| Mar 9, 2018 | Pamela Sedmak became Executive Vice President |
| Mar 9, 2018 | Mark Lowell Keim became Executive Vice President |
| Mar 9, 2018 | Joseph W Cpa White no longer listed as a 10% owner in SEC filings |
| Mar 2, 2018 | Lisa A Rubino reported in an SEC filing no longer being Senior Vice President |
| Mar 2, 2018 | Joseph W Cpa White first listed as a 10% owner in an SEC filing |
| Mar 2, 2018 | Joseph W Cpa White first listed as Chief Financial Officer in an SEC filing |
| Feb 28, 2018 | John C Molina reported in an SEC filing no longer being a director |
| Feb 6, 2018 | Terry Bayer reported in an SEC filing no longer being Chief Operating Officer |
| Dec 13, 2017 | J Mario Md Molina reported in an SEC filing no longer being a director |
| Nov 6, 2017 | Joseph M Zubretsky became a director |
| Nov 6, 2017 | Joseph M Zubretsky became President & CEO |
| Jun 7, 2017 | Joseph W Cpa White no longer listed as Chief Accounting Officer in SEC filings |
| May 4, 2017 | John C Molina no longer listed as CFO in SEC filings |
| May 4, 2017 | J Mario Md Molina no longer listed as President & CEO in SEC filings |
Not reported recently (9)
- Daniel Cooperman · Last reported as a director in an SEC filing dated Apr 2, 2025
- Marc Russo · Last reported as EVP, Health Plans in an SEC filing dated Aug 7, 2023
- Garrey Carruthers · Last reported as a director in an SEC filing dated Apr 2, 2021
- Pamela Sedmak · Last reported as Executive Vice President in an SEC filing dated Mar 3, 2020
- Charles Z Fedak · Last reported as a director in an SEC filing dated Apr 3, 2019
- Molina Marital Trust · Last reported as a 10% owner in an SEC filing dated Oct 18, 2017
- Mary R Molina Living Trust · Last reported as a 10% owner in an SEC filing dated Oct 18, 2017
- Frank E MD Murray · Last reported as a director in an SEC filing dated Oct 2, 2017
- Keith Wilson · Last reported as Chief Medical Officer in an SEC filing dated Jul 5, 2017
Compiled from SEC filings by the company and its directors and officers. Dates are as stated in those filings. Where no filing says when someone left, we show the last filing that listed them.
MOH Proposed Insider Sales (Form 144)
Latest: 2026-05-14
? Form 144 Guide
Last 30d:
0 filings
· Last 90d:
0 filings
What is Form 144? A notice of intent to sell restricted or control stock under Rule 144. Affiliates (officers, directors, 10%+ owners) and holders of restricted shares must file Form 144 when planning to sell more than 5,000 shares or $50,000 in any 3-month rolling window.
How it relates to Form 4: Form 144 is filed before the trade (up to 90 days in advance); Form 4 is filed within 2 business days after the trade executes. Not every Form 144 results in a sale — the filer may cancel or delay. Look for the corresponding Form 4 on the Insider Activity card to confirm a sale actually happened.
10b5-1 plans: Trades made under a pre-scheduled Rule 10b5-1 plan are not discretionary — they execute automatically on dates set months earlier, regardless of news. High 10b5-1 percentages mean less per-filing signal value, though cumulative selling volume still matters.
"Notice value": Aggregate market value the filer wrote into the Form 144 — i.e. the size of the planned sale, not necessarily the executed dollars. An amended notice (Form 144/A) replaces the original it amends, and cancelled notices are dropped, so neither is double-counted above. A filed value that is clearly inconsistent with the share count at the stock's price (a filer typo) shows as a dash and is left out of the totals.
Source & freshness: Sourced from public Form 144 filings. Refreshed daily; new filings typically appear here the morning after they are filed.
| Filed | Filer | Role | Shares | Notice Value | Planned Sale | Broker | Plan | Link |
|---|---|---|---|---|---|---|---|---|
| 2026-05-14 | MAURICE HEBERT | Officer | 600 | $114.9K | 2026-05-14 | Morgan Stanley Smith Barney LLC … | — | EDGAR |
| 2026-05-11 | JEFF D BARLOW | Officer | 17,811 | $3.31M | 2026-05-11 | Morgan Stanley Smith Barney LLC … | — | EDGAR |
| 2026-03-12 | ROMNEY RONNA | Director | 506 | $74.2K | 2026-03-11 | Fidelity Brokerage Services LLC | — | EDGAR |
| 2025-11-24 | Schapiro Richard M | Director | 357 | $50.5K | 2025-11-24 | Piper Sandler and Co | — | EDGAR |
| 2025-08-04 | ROMNEY RONNA | Director | 700 | $110.6K | 2025-08-04 | FIDELITY BROKERAGE SERVICES LLC | — | EDGAR |
| 2025-05-21 | THE DALE B. WOLF REVOCABLE TRUST | Director | 1,500 | $484.3K | 2025-05-21 | Morgan Stanley Smith Barney LLC … | — | EDGAR |
| 2025-05-02 | ORLANDO STEVEN J | Director | 1,000 | $315.0K | 2025-05-05 | Merril Lynch Wealth Management | — | EDGAR |
| 2025-04-30 | Joseph M. Zubretsky | President / CEO / Director | 87,500 | $27.98M | 2025-04-30 | J.P. Morgan Securities LLC | — | EDGAR |
| 2025-04-29 | Schapiro Richard M | Director | 669 | $214.2K | 2025-04-29 | Piper Sandler & Co Inc | — | EDGAR |
| 2025-03-03 | ORLANDO STEVEN J | Director | 1,000 | $301.0K | 2025-03-03 | Merrill Lynch | — | EDGAR |
Notice value is the aggregate market value the filer states they intend to sell — not a confirmed transaction. Compare to Insider Activity (Form 4) to see which planned sales actually executed. Market-wide feed: Planned sales (Form 144).
Recent SEC Filings
Latest: 2026-05-11
Current reports — material events the company must disclose within 4 business days (earnings releases, M&A, executive changes, etc.).
| Filing Date | Accession | Link |
|---|---|---|
| 2026-05-11 | 0001179929-26-000026 | EDGAR |
| 2026-05-08 | 0001437749-26-015766 | EDGAR |
| 2026-04-22 | 0001179929-26-000020 | EDGAR |
| 2026-02-26 | 0001437749-26-005871 | EDGAR |
| 2026-02-06 | 0001437749-26-003384 | EDGAR |
| 2026-02-05 | 0001179929-26-000002 | EDGAR |
| 2025-11-20 | 0001437749-25-035866 | EDGAR |
| 2025-11-18 | 0001437749-25-035490 | EDGAR |
| 2025-11-17 | 0001437749-25-035305 | EDGAR |
| 2025-11-14 | 0001437749-25-035194 | EDGAR |
Annual report — audited financial statements, MD&A, risk factors. Filed 60–90 days after fiscal year-end.
| Filing Date | Accession | Link |
|---|---|---|
| 2026-02-10 | 0001179929-26-000005 | EDGAR |
| 2025-02-11 | 0001179929-25-000023 | EDGAR |
| 2024-02-13 | 0001179929-24-000033 | EDGAR |
| 2023-02-13 | 0001179929-23-000025 | EDGAR |
| 2022-02-14 | 0001179929-22-000025 | EDGAR |
| 2021-02-16 | 0001179929-21-000024 | EDGAR |
| 2020-02-14 | 0001179929-20-000026 | EDGAR |
| 2019-02-19 | 0001179929-19-000032 | EDGAR |
| 2018-03-01 | 0001179929-18-000040 | EDGAR |
| 2017-03-01 | 0001179929-17-000046 | EDGAR |
Quarterly report — unaudited financials and MD&A. Filed 40–45 days after each of the first three fiscal quarters.
| Filing Date | Accession | Link |
|---|---|---|
| 2026-04-23 | 0001179929-26-000023 | EDGAR |
| 2025-10-23 | 0001179929-25-000128 | EDGAR |
| 2025-07-24 | 0001179929-25-000119 | EDGAR |
| 2025-04-24 | 0001179929-25-000070 | EDGAR |
| 2024-10-24 | 0001179929-24-000151 | EDGAR |
| 2024-07-25 | 0001179929-24-000123 | EDGAR |
| 2024-04-25 | 0001179929-24-000089 | EDGAR |
| 2023-10-26 | 0001179929-23-000132 | EDGAR |
| 2023-07-27 | 0001179929-23-000098 | EDGAR |
| 2023-04-27 | 0001179929-23-000069 | EDGAR |
ETF Holders
147 ETFs hold MOH
25 shown · $2.01B total exposure · 0.16% AUM-weighted avg weight
| # | ETF | Provider | Weight | $ Exposure | ETF AUM | As Of |
|---|---|---|---|---|---|---|
| 1 | IJH iShares Core S&P Mid-Cap ETF | iShares (BlackRock) | 0.33% | $402.0M | $122.0B | 2026-10-21 |
| 2 | VTI Vanguard Morningstar Total Stock Market ETF | Vanguard | 0.01% | $313.7M | — | 2026-09-30 |
| 3 | VB Vanguard Morningstar Small-Cap ETF | Vanguard | 0.12% | $222.2M | — | 2026-09-30 |
| 4 | VBR Vanguard Morningstar Small-Cap Value ETF | Vanguard | 0.22% | $144.6M | — | 2026-09-30 |
| 5 | VXF Vanguard Extended Market ETF | Vanguard | 0.12% | $111.2M | — | 2026-09-30 |
| 6 | DFAT Dimensional US Targeted Value ETF | Dimensional | 0.29% | $89.1M | — | 2026-10-21 |
| 7 | MDY State Street® SPDR® S&P MIDCAP 400® ETF Trust | SPDR (State Street) | 0.32% | $84.3M | $26.0B | 2026-10-21 |
| 8 | VXUS Vanguard Total International Stock ETF | Vanguard | 0.01% | $72.6M | — | 2026-09-30 |
| 9 | SPMD State Street® SPDR® Portfolio S&P 400™ Mid Cap ETF | SPDR (State Street) | 0.33% | $60.6M | $18.5B | 2026-10-21 |
| 10 | IJJ iShares S&P Mid-Cap 400 Value ETF | iShares (BlackRock) | 0.67% | $57.0M | $8.6B | 2026-10-21 |
| 11 | IEMG iShares Core MSCI Emerging Markets ETF | iShares (BlackRock) | 0.04% | $54.2M | $148.1B | 2026-10-21 |
| 12 | DFAS Dimensional US Small Cap ETF | Dimensional | 0.15% | $51.1M | — | 2026-10-21 |
| 13 | VEA Vanguard FTSE Developed Markets ETF | Vanguard | 0.02% | $48.0M | — | 2026-09-30 |
| 14 | IWR iShares Russell Mid-Cap ETF | iShares (BlackRock) | 0.08% | $46.3M | $57.2B | 2026-10-21 |
| 15 | DFAC Dimensional US Core Equity 2 ETF | Dimensional | 0.05% | $42.5M | — | 2026-10-21 |
| 16 | VHT Vanguard Health Care ETF | Vanguard | 0.14% | $30.1M | — | 2026-09-30 |
| 17 | RWK Invesco S&P MidCap 400 Revenue ETF | Invesco | 1.99% | $25.9M | — | 2026-10-21 |
| 18 | IWD iShares Russell 1000 Value ETF | iShares (BlackRock) | 0.03% | $24.6M | $84.8B | 2026-10-21 |
| 19 | SCHM Schwab U.S. Mid-Cap ETF | Nport | 0.17% | $24.2M | — | 2026-05-31 |
| 20 | IHF iShares U.S. Healthcare Providers ETF | iShares (BlackRock) | 1.37% | $19.0M | $1.4B | 2026-10-21 |
| 21 | MDYV State Street® SPDR® S&P 400™ Mid Cap Value ETF | SPDR (State Street) | 0.67% | $18.4M | $2.8B | 2026-10-21 |
| 22 | VSS Vanguard FTSE All-World EX-US Small-Cap Index Fund | Vanguard | 0.12% | $18.1M | — | 2026-09-30 |
| 23 | FNDX Schwab Fundamental U.S. Large Company ETF | Nport | 0.07% | $17.6M | — | 2026-05-31 |
| 24 | IWS iShares Russell Mid-Cap Value ETF | iShares (BlackRock) | 0.11% | $16.8M | $15.7B | 2026-10-21 |
| 25 | IVOO Vanguard S&P Mid-Cap 400 ETF | Vanguard | 0.29% | $16.5M | — | 2026-09-30 |
Fundamentals
Quarterly filings sourced from SEC 10-Q / 10-K reports. TTM tiles aggregate the most recent four quarters; bars show the last ~12 quarters oldest → newest.
Metrics
- Revenue — top-line sales. Look for consistent YoY growth; seasonal businesses need same-quarter comparisons (Q4 '24 vs Q4 '23).
- Net Income — bottom-line profit after all expenses. Can be volatile from one-time items; red bars = net loss.
- Diluted EPS — net income per share assuming options/converts are exercised. Direct input to the P/E ratio.
- Operating Cash Flow — cash generated from core operations, before capex and financing. Harder to manipulate than net income; growing OCF is a quality signal.
How to read the bars
- Sequential growth — quarter-over-quarter trend. Accelerating bars are a momentum signal.
- YoY growth — compare to the same quarter a year earlier to remove seasonality.
- Quality — OCF should roughly track Net Income over time. Large divergence (net income ≫ OCF) flags accruals risk.
- Margins — scan the bar ratios: Net Income / Revenue tells you margin trend without needing a separate chart.
TTM (trailing-twelve-month) smooths seasonality and is used for the P/E calculation. Filings appear 30–90 days after the period closes.
Trailing P/E
2091.50
TTM Diluted EPS
$0.10
TTM Revenue
$44.32B
TTM Net Income
$-7.00M
TTM Op. Cash Flow
$365.00M
Quarterly figures (12 quarters)
| Quarter | Period End | Revenue | Net Income | Diluted EPS | Op. Cash Flow |
|---|---|---|---|---|---|
| Q2 '26 | 2026-06-30 | $10.75B | $60.00M | $1.19 | $-294.00M |
| Q1 '26 | 2026-03-31 | $10.68B | $14.00M | $0.27 | $1.08B |
| Q4 '25 | 2025-12-31 | $11.44B | $-160.00M | $-2.87 | $-298.00M |
| Q3 '25 | 2025-09-30 | $11.46B | $79.00M | $1.51 | $-125.00M |
| Q2 '25 | 2025-06-30 | $11.30B | $255.00M | $4.75 | $-302.00M |
| Q1 '25 | 2025-03-31 | $11.02B | $298.00M | $5.45 | $190.00M |
| Q4 '24 | 2024-12-31 | $10.56B | $251.00M | $4.45 | $-224.00M |
| Q3 '24 | 2024-09-30 | $10.32B | $326.00M | $5.65 | $873.00M |
| Q2 '24 | 2024-06-30 | $9.74B | $301.00M | $5.17 | $-219.00M |
| Q1 '24 | 2024-03-31 | $9.80B | $301.00M | $5.17 | $214.00M |
| Q4 '23 | 2023-12-31 | $8.85B | $216.00M | $3.69 | $-690.00M |
| Q3 '23 | 2023-09-30 | $8.44B | $245.00M | $4.21 | $949.00M |
Q2 2026 • period ending 2026-06-30 • filed 2026-07-23
Valuation
Ratios derived from TTM financials and the current market price, sampled daily. History chart shows how expensive the stock is today relative to its own recent past.
Price Multiples
- P/E — price / TTM earnings. Rough market rule: 10–15 value, 15–25 market, >30 growth/premium. Negative when earnings are negative.
- P/B — price / book value. Useful for financials and asset-heavy names; meaningless for asset-light software.
- P/S — price / TTM revenue. Useful when earnings are negative or noisy (early-stage growth).
- EV/EBITDA — capital-structure-neutral. <10 cheap, 10–15 reasonable, >20 rich. Good for comparing across leverage profiles.
- EV/Sales — like P/S but accounts for debt + cash. Compare within sector.
Profitability & Yields
- ROE — return on equity. >15% strong, >25% exceptional. Caution: high leverage inflates ROE.
- ROA — return on assets. Leverage-neutral; >5% solid, >10% exceptional.
- Div Yield — annual dividend / price. Compare to 10Y Treasury; sustained yield >6% often signals distress.
- FCF Yield — free cash flow / market cap. >5% is attractive; negative means burning cash.
Balance Sheet
- Debt/Equity — leverage. <1 conservative, >2 aggressive. Sector-dependent (utilities naturally high, tech low).
- Current Ratio — short-term liquidity. >1.5 comfortable, <1 raises short-term solvency flags.
Reading the history chart
- Compare current level to the 3-year band: near the high end = relatively expensive; near the low = relatively cheap.
- Multiples expanding while earnings are flat = sentiment-driven rally.
- Multiples compressing while earnings grow = value coming from fundamentals.
P/E
2091.50
P/B
2.60
P/S
0.24
EV/EBITDA
45.93
EV/Sales
0.22
ROE
-0.2%
ROA
-0.0%
Div Yield
0.00%
FCF Yield
3.36%
Debt/Equity
0.95
Current Ratio
—
Market Cap
$10.86B
as of 2026-10-23
Short Interest & Float
Regulatory short-interest reports publish on a bi-weekly settlement cadence; short-volume is reported daily by the trade-reporting facilities. Float is derived from insider-ownership filings.
Metric definitions
- Short Interest — total shares currently sold short as of the settlement date. Lags real time by ~8 business days.
- SI % of Float — short interest / free float. The key crowding metric.
- Days to Cover — short interest / avg daily volume. How many full trading days it would take shorts to buy back. High DTC + catalyst = squeeze fuel.
- Short Vol Ratio — today's short-sale volume / total volume. Intraday selling pressure proxy (not the same as short interest).
- Free Float — shares available for public trading (total shares minus insider / restricted).
- Float % — free float / shares outstanding. <50% = tightly held, more prone to squeezes.
How to read the signals
- SI % of Float < 5% — typical, no particular signal.
- 5–15% — elevated; watch for catalysts (earnings, guidance, macro).
- 15–30% — heavily shorted; tight-float names in this range have produced notable squeezes historically.
- >30% — extreme; borrow is likely expensive and squeeze risk is material.
- Days to Cover > 5 combined with high SI% amplifies squeeze potential.
History chart
- Trend matters more than level. Rapidly rising short interest often precedes negative catalysts or heavy hedging.
- A sudden drop in SI after a rally may indicate a squeeze in progress.
Short interest is reported mid-month and end-of-month; short volume is daily.
Short Interest
2.89M
SI % of Float
5.61%
Days to Cover
4.76
Short Vol Ratio
68.8%
Free Float
51.45M
Float %
98.6%
Short interest 2026-09-30 • Short volume 2026-10-22 • Float 2026-08-14